NCT00426764 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- groups
- description
- Participants received romidepsin 14 mg/m\^2 administered intravenously over 4 hours on Days 1, 8, and 15 of a 28-day cycle. Participants continued on monthly cycles of romidepsin. The planned duration of study therapy was 6 cycles. Participants who responded could continue beyond 6 cycles until disease progression or other withdrawal criteria were met. For participants treated for 12 or more cycles, maintenance dosing (2 doses per cycle) was permitted.
- id
- BG000
- title
- Romidepsin
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.83
- value
- 59.4
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 42
- title
- Female
- measurements
- group Id
- BG000
- value
- 89
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 116
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 7
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Black
- categories
- measurements
- group Id
- BG000
- value
- 3
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 4
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.2348
- value
- 1.84
- denoms
- counts
- group Id
- BG000
- value
- 128
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- participants with a Baseline measurement
- title
- Body Surface Area (BSA)
- unit Of Measure
- m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 46
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 66
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 17
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Missing
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Unknown
- description
- The ECOG scale is as follows: Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair \> 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or Chair.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 2.6654
- value
- 2.268
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Duration of peripheral T-cell lymphoma (PTCL)
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- PTCL Unspecified (NOS)
- categories
- measurements
- group Id
- BG000
- value
- 27
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Angioimmunoblastic T-cell lymphoma (AITL)
- categories
- measurements
- group Id
- BG000
- value
- 21
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- ALK-1 negative ALCL
- categories
- measurements
- group Id
- BG000
- value
- 6
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Enteropathy-type T-cell lymphoma
- categories
- measurements
- group Id
- BG000
- value
- 3
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Subcutaneous panniculitis-like T-cell lymphoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- ALK-1 positive ALCL
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Cutaneous γδ T-cell lymphoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Extranodal NK/T cell lymphoma nasal type
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Transformed mycosis fungoides
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Unknown
- description
- ALK-1=anaplastic lymphoma kinase; ALCL=anaplastic large cell lymphoma
- param Type
- COUNT_OF_PARTICIPANTS
- title
- PTCL Subtype Based on Central Diagnosis
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- groups
- description
- Participants received romidepsin 14 mg/m\^2 administered intravenously over 4 hours on Days 1, 8, and 15 of a 28-day cycle. Participants continued on monthly cycles of romidepsin. The planned duration of study therapy was 6 cycles. Participants who responded could continue beyond 6 cycles until disease progression or other withdrawal criteria were met. For participants treated for 12 or more cycles, maintenance dosing (2 doses per cycle) was permitted.
- id
- BG000
- title
- Romidepsin
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 12.83
- value
- 59.4
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 42
- title
- Female
- measurements
- group Id
- BG000
- value
- 89
- title
- Male
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 116
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 7
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Black
- categories
- measurements
- group Id
- BG000
- value
- 3
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 4
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.2348
- value
- 1.84
- denoms
- counts
- group Id
- BG000
- value
- 128
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- population Description
- participants with a Baseline measurement
- title
- Body Surface Area (BSA)
- unit Of Measure
- m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 46
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 66
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 17
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Missing
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Unknown
- description
- The ECOG scale is as follows: Grade 0: Fully active, able to carry on all pre-disease activities without restriction; Grade 1: Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; Grade 2: Ambulatory and capable of all self-care but unable to work. Up and about more than 50% of waking hours; Grade 3: Capable of only limited self-care, confined to bed or chair \> 50% of waking hours; Grade 4: Completely disabled. Cannot carry on any self-care. Confined to bed or Chair.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 2.6654
- value
- 2.268
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Duration of peripheral T-cell lymphoma (PTCL)
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 69
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- PTCL Unspecified (NOS)
- categories
- measurements
- group Id
- BG000
- value
- 27
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Angioimmunoblastic T-cell lymphoma (AITL)
- categories
- measurements
- group Id
- BG000
- value
- 21
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- ALK-1 negative ALCL
- categories
- measurements
- group Id
- BG000
- value
- 6
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Enteropathy-type T-cell lymphoma
- categories
- measurements
- group Id
- BG000
- value
- 3
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Subcutaneous panniculitis-like T-cell lymphoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- ALK-1 positive ALCL
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Cutaneous γδ T-cell lymphoma
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Extranodal NK/T cell lymphoma nasal type
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Transformed mycosis fungoides
- categories
- measurements
- group Id
- BG000
- value
- 1
- denoms
- counts
- group Id
- BG000
- value
- 131
- units
- Participants
- title
- Unknown
- description
- ALK-1=anaplastic lymphoma kinase; ALCL=anaplastic large cell lymphoma
- param Type
- COUNT_OF_PARTICIPANTS
- title
- PTCL Subtype Based on Central Diagnosis
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle